As of and for the Six Months Ended June 30, 2025

As Previously

Reported

Adjustment

As Revised

Discontinued

Operations

As

Reported

Consolidated Statement of Operations:

Telehealth revenue, net

$

101,020,153

$

(1,113,372

)

$

99,906,781

$

-

$

99,906,781

Total revenues, net

$

127,915,941

$

(1,113,372

)

$

126,802,569

$

26,895,788

$

99,906,781

Gross profit

$

111,841,321

$

(1,113,372

)

$

110,727,949

$

25,796,332

$

84,931,617

Operating income (loss)

$

1,636,152

$

(1,113,372

)

$

522,780

$

4,051,383

$

(3,528,603

)

Net income (loss)

$

346,850

$

(1,113,372

)

$

(766,522

)

$

-

$

(766,522

)

Net loss attributable to LifeMD, Inc.

$

(690,070

)

$

(1,113,372

)

$

(1,803,442

)

$

-

$

(1,803,442

)

Net loss attributable to LifeMD, Inc. common stockholders

$

(2,243,195

)

$

(1,113,372

)

$

(3,356,567

)

$

-

$

(3,356,567

)

Basic loss per share attributable to LifeMD, Inc. common stockholders

$

(0.05

)

$

(0.03

)

$

(0.08

)

$

-

$

(0.08

)

Diluted loss per share attributable to LifeMD, Inc. common stockholders

$

(0.05

)

$

(0.03

)

$

(0.08

)

$

-

$

(0.08

)

Consolidated Statement of Changes in Stockholders’ Equity (Deficit):

Accumulated deficit

$

238,496,413

$

4,711,085

$

243,207,498

$

-

$

243,207,498

Non-controlling interest

$

(2,164,934

)

$

(88,961

)

$

(2,253,895

)

$

-

$

(2,253,895

)

Consolidated Statement of Cash Flows:

Net income (loss)

346,850

$

(1,113,372

)

$

(766,522

)

$

-

$

(766,522

)

Accounts receivable

$

887,684

$

645,683

$

1,533,367

$

19,421

$

1,513,946

Deferred revenue

$

(2,690,893

)

$

(32,312

)

$

(2,723,205

)

$

(137,042

)

$

(2,586,163

)

Accrued expenses

$

(5,865,264

)

500,000

(5,365,264

)

(104,771

)

(5,260,493

)

Net cash provided by operating activities

$

11,707,834

$

-

$

11,707,834

$

-

$

11,707,834